Filing Details

Accession Number:
0001179110-19-006608
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-23 20:21:09
Reporting Period:
2019-05-22
Accepted Time:
2019-05-23 20:21:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1034842 Rigel Pharmaceuticals Inc RIGL Pharmaceutical Preparations (2834) 943248524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509688 L Dean Schorno Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd.
South San Francisco CA 94080
Evp &Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-22 46,726 $2.13 46,726 No 4 P Direct
Common Stock Acquisiton 2019-05-22 3,274 $2.13 50,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct